EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1 −/− mouse model of collagen VI‐related myopathies

Sonia Calabrò, Leonardo Nogara, Yongzhi Jian, Manuel Valentin, Dario Bizzotto, Paola Braghetta, Loris Russo, Lisa Gambarotto, Bert Blaauw, Said Hashemolhosseini, Paolo Bonaldo, Matilde Cescon iD

Clinical and Translational Medicine · 2024

DOI: 10.1002/ctm2.1688 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Sonia Calabrò und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, University of Padova, Padova, Italy. Hauptthemen laut MEDLINE: Disease Models, Animal, Collagen Type VI, Muscular Atrophy, Neuromuscular Junction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AFM Telethon, University of Padova, Telethon Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalCollagen Type VIMuscular AtrophyNeuromuscular JunctionAnimalsMiceMuscular DiseasesDrug Repositioning

Substanzen

Collagen Type VI

Autor:innen und Institutionen

  • Department of Molecular Medicine, University of Padova, Padova, Italy.
  • Department of Biology, University of Padova, Padova, Italy.
  • Department of Biomedical Sciences, University of Padova, Padova, Italy.
  • Venetian Institute of Molecular Medicine, Padova, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy.
  • Institut für Biochemie, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

ORCID-Profile: Matilde Cescon

Förderung

  • AFM Telethon
  • University of Padova
  • Telethon Foundation
  • Italian Ministry of Education, University and Research
  • German Research Council
  • National Center for Gene Therapy and Drugs Based on RNA Technology
  • National Recovery and Resilience Plan (NRRP)
  • Strengthening research structures for supporting the creation of National Centres, national R&D leaders on some Key Enabling Technologies

Zitieren

APA

Calabrò, S., Nogara, L., Jian, Y., Valentin, M., Bizzotto, D., Braghetta, P., Russo, L., Gambarotto, L., Blaauw, B., Hashemolhosseini, S., Bonaldo, P., & Cescon, M. (2024). Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1 −/− mouse model of collagen VI‐related myopathies. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1688

Vancouver

Calabrò S, Nogara L, Jian Y, Valentin M, Bizzotto D, Braghetta P, et al. Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1 −/− mouse model of collagen VI‐related myopathies. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1688

BibTeX
@article{Calabr2024,
  author = {Calabrò, Sonia and Nogara, Leonardo and Jian, Yongzhi and Valentin, Manuel and Bizzotto, Dario and Braghetta, Paola and Russo, Loris and Gambarotto, Lisa and Blaauw, Bert and Hashemolhosseini, Said and Bonaldo, Paolo and Cescon, Matilde},
  title = {Salbutamol repurposing ameliorates neuromuscular junction defects and muscle atrophy in Col6a1 −/− mouse model of collagen VI‐related myopathies},
  journal = {Clinical and Translational Medicine},
  year = {2024},
  doi = {10.1002/ctm2.1688}
}
Kostenlos starten →